amiodarone has been researched along with tolvaptan in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barbagelata, NA; Bramer, SL; Elizari, MV; Grinfeld, LR; Lerman, J; Orlandi, C; Sekar, K; Shoaf, SE; Trongé, J; Wang, Z | 1 |
Kinugawa, K; Kugai, T; Nakamura, M; Sunagawa, O | 1 |
Akutsu, S; Hoshikawa, K; Kawakami, J; Maekawa, Y; Mino, Y; Naito, T; Saotome, M | 1 |
1 review(s) available for amiodarone and tolvaptan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for amiodarone and tolvaptan
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Tolvaptan administration does not affect steady state amiodarone concentrations in patients with cardiac arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Antidiuretic Hormone Receptor Antagonists; Arrhythmias, Cardiac; Benzazepines; Drug Interactions; Electrocardiography; Female; Humans; Male; Middle Aged; Tolvaptan | 2005 |
Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
Topics: Adult; Amiodarone; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Delirium; Heart Failure; Heart-Assist Devices; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Sodium Channel Blockers; Tolvaptan | 2017 |
Stereoselective interaction of tolvaptan with amiodarone under racemic metabolic impact by CYP3A5 genotypes in heart failure patients.
Topics: Amiodarone; Cytochrome P-450 CYP3A; Genotype; Heart Failure; Humans; Immunosuppressive Agents; Tolvaptan | 2022 |